Eli Lilly and Company United States of America (USA)
Research
Date range: 1 February 2022 - 31 January 2023
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Eli Lilly and Company published between 1 February 2022 - 31 January 2023 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 29 | 7.12 |
Outputs by subject (Share)
| Subject | Count | Share |
|---|---|---|
| Chemistry | 4 | 1.19 |
| Life Sciences | 24 | 6.59 |
| Physical Sciences | 3 | 0.17 |
| Earth & Environmental Sciences | 1 | 0.17 |
Share output for the past 5 years
| 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| 5.93 | 7.69 | 8.38 | 5.04 | 5.98 |
Nature Strategy Reports
Nature Strategy Reports gives you simple insights to support decisions that impact your organisation
The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.
Collaboration
Date range: 1 February 2022 - 31 January 2023
International vs. domestic collaboration by Share
- 46.62% Domestic (109 institutions)
- 53.38% International (369 institutions)
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Eli Lilly and Company by Share*
-
Eli Lilly and Company and Memorial Sloan Kettering Cancer Center (MSKCC)
(2.45)
-
Eli Lilly and Company and Harvard University
(1.98)
-
Eli Lilly and Company and Cornell University
(1.68)
-
Eli Lilly and Company and National Institutes of Health (NIH)
(1.56)
-
Eli Lilly and Company and The University of North Carolina at Chapel Hill (UNC)
(1.19)
-
Eli Lilly and Company and University of California, San Diego (UC San Diego)
(1.17)
-
Eli Lilly and Company and University of California, San Francisco (UCSF)
(1.06)
-
Eli Lilly and Company and Emory University
(1.00)
-
Eli Lilly and Company and ConfometRx
(1.00)
-
Eli Lilly and Company and Advanced Testing Laboratory (ATL)
(0.75)
Top 10 international collaborators with Eli Lilly and Company by Share*
-
Eli Lilly and Company and Immunocore Limited
(0.92)
-
Eli Lilly and Company and University of Surrey
(0.89)
-
Eli Lilly and Company and Walter and Eliza Hall Institute of Medical Research (WEHI)
(0.83)
-
Eli Lilly and Company and University of Oxford
(0.80)
-
Eli Lilly and Company and Sun Yat-sen University (SYSU)
(0.79)
-
Eli Lilly and Company and The University of Melbourne (UniMelb)
(0.76)
-
Eli Lilly and Company and University of Exeter
(0.56)
-
Eli Lilly and Company and UK Dementia Research Institute (UK DRI)
(0.52)
-
Eli Lilly and Company and AstraZeneca plc
(0.50)
-
Eli Lilly and Company and UK DRI at Imperial College London (UK DRI ICL)
(0.50)
Relationships
Eli Lilly and Company
- Disarm Therapeutics Inc.
- Eli Lilly China
- Eli Lilly Danmark A/S
- Eli Lilly GmbH
- Eli Lilly Italia SpA
- Eli Lilly Japan K.K.
- Eli Lilly Poland Sp. o.o.
- Eli Lilly S.A.
- Eli Lilly Spain
- Eli Lilly and Company France
- Eli Lilly and Company Ltd.
- Lilly Deutschland GmbH
- Lilly Medical Center
- Lilly Research Center in China
- Lilly Singapore Centre for Drug Discovery
- Loxo Oncology Inc.
- Novartis Animal Health Inc.
Affiliated joint institutions and consortia
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.